PointCare Technologies, Inc. operates as a medical diagnostics company. It provides technologies for the point of treatment diagnosis. The company’s products include the PointCare NOW, a flow cytometry system that combines CD4 lymphocyte counting and hematology testing, providing results for CD4 count, CD4 percent, white cell count, hemoglobin concentration, lymphocyte count and percent, neutrophil count and percent, monocyte count and percent, and eosinophil count and percent with one analysis. The PointCare NOW is used for managing antiretroviral therapy for HIV/AIDS patients. PointCare Technologies has a strategic partnership with C2 Diagnostics. The company was founded in 2002 and is based in Marlborough, Massachusetts.